[Biological activity of regulatory peptides in model experiments in vitro].
Kozina. L S LS; Arutiunian. A V AV; Stvolinskiĭ. S L SL; Khavinson. V Kh VKh
Key Findings
- The peptides do not have direct antioxidant activity but can limit lipid peroxidation of human lipoproteins by altering their structure.
- They increase the resistance of red blood cell membranes to osmotic stress, reducing hemolysis.
- All peptides except epitalon raise steady‑state intracellular ROS levels while decreasing the proportion of dead neurons, suggesting a role in apoptosis/necrosis regulation.
Practical Outcomes
- For DIY health enthusiasts, the data hint that these short peptides might help protect cells from oxidative damage and support brain health, but the work is limited to cell cultures. No dosing guidelines or human safety data are provided, so any supplementation would be experimental and should be approached with caution.
Summary
The study looked at tiny proteins called pinealon, vesugen, vilon and epitalon in test‑tube experiments. They didn’t act as direct antioxidants, but they could slow down fat damage in human lipoproteins, make red blood cells tougher, and seem to protect brain cells from dying, possibly by influencing cell death pathways.
Abstract
Biological effects of short regulatory peptides, pinealon, vesugen, vilon and epitalon were studied in model experiments in vitro. These peptides were found not to demonstrate direct antioxidant activity but be able to restrict lipid peroxidation of human lipoproteins by modification of their structure. The short peptides increase stability of red blood cell membranes toward osmotic hemolysis. They also elevate the stationary level of intracellular reactive oxygen species and at the same time decrease (all excepting epitalon) percent of dead cells in neuronal population. The suggestion was made that under in vivo conditions, short peptides may participate in apoptosis/necrosis regulation.
Study Information
pubmed
2008